CHM.CN Stock Surges 900% on Waverunner Capital Rebranding

CHM.CN stock has delivered a dramatic 900% surge, climbing to C$0.05 per share on the Canadian CNQ exchange. This explosive move reflects Waverunner Capital Inc.’s strategic transformation from Chemistree Technology into a venture capital powerhouse. The North Vancouver-based firm now focuses on early-stage investments, seed funding, and growth capital across Europe and North America. With a market cap of C$37.2 million and 744 million shares outstanding, CHM.CN represents a high-risk, high-reward opportunity for investors tracking emerging venture plays. The stock’s dramatic rebound signals renewed market interest in the company’s repositioned business model.

CHM.CN Stock Price Action and Volume Dynamics

CHM.CN stock opened at C$0.05 with a staggering 900% gain from its previous close of C$0.005. The stock traded within a tight range, with both day low and day high at C$0.05, indicating strong buyer conviction at this price level. Year-to-date performance shows the stock has recovered from its C$0.05 year low to match current levels, though it remains well below the C$0.10 year high set earlier.

Average daily volume stands at 28,908 shares, suggesting moderate liquidity for retail traders. The 50-day moving average sits at C$0.0424, while the 200-day average rests at C$0.0481, both below current price levels. This positioning indicates CHM.CN has broken above intermediate resistance, potentially attracting technical traders seeking momentum plays on the CNQ exchange.

Waverunner Capital’s Business Model and Investment Focus

Waverunner Capital Inc. specializes in early-stage venture capital, seed funding, bridge financing, and growth capital investments across Europe and North America. The firm targets equity investments between C$500,000 and C$1 million, with enterprise values ranging from C$2 million to C$5 million. This focused approach allows the company to maintain hands-on involvement in portfolio companies.

The venture firm holds diversified investments spanning renewable energy (wind and solar), plant-based wellness, consumer-targeted biotechnology, and resources sectors. CEO Karl Eric Kottmeier leads the organization from North Vancouver, BC. Waverunner makes investments through both its own balance sheet and personal capital, creating alignment with limited partners. This dual-capital approach differentiates the firm in a competitive venture landscape.

Financial Metrics and Valuation Concerns

CHM.CN presents mixed financial signals that warrant careful analysis. The company reports negative earnings per share of -C$0.01 with a negative PE ratio of -5.0, reflecting ongoing losses. Net income per share stands at -C$0.0595, while operating cash flow per share is -C$0.0045, both indicating cash burn.

Key balance sheet metrics show concerning liquidity. The current ratio of 0.097 falls well below the healthy 1.0 threshold, suggesting potential short-term payment challenges. Book value per share is negative at -C$0.1422, indicating shareholders’ equity is underwater. However, the company maintains C$0.0080 cash per share. These metrics highlight that CHM.CN remains a speculative venture play rather than a fundamentally sound investment.

Market Sentiment and Trading Activity

The 900% price surge reflects renewed market enthusiasm for Waverunner Capital’s repositioned strategy. Institutional and retail traders appear to be reassessing the venture capital opportunity following the June 2024 rebranding from Chemistree Technology. The tight trading range at C$0.05 suggests buyers and sellers are establishing positions at this psychological level.

Liquidation pressures remain manageable given the modest average volume of 28,908 shares daily. However, the stock’s penny-stock status means wide bid-ask spreads could impact execution for larger orders. Track CHM.CN on Meyka for real-time updates on volume spikes and price movements. The CNQ exchange listing provides Canadian retail investors direct access to this emerging venture capital play.

Meyka AI Grade and Investment Outlook

Meyka AI rates CHM.CN with a grade of B, suggesting a HOLD recommendation with a total score of 61.33. This grade factors in S&P 500 benchmark comparison (11%), sector performance (16%), industry comparison (16%), financial growth (12%), key metrics (16%), forecasts (8%), analyst consensus (14%), and fundamental growth (7%).

The B-grade reflects balanced risk-reward dynamics. While Waverunner’s venture capital pivot offers growth potential, negative cash flows and weak balance sheet metrics create downside risks. These grades are not guaranteed and we are not financial advisors. Investors should conduct thorough due diligence before committing capital to this speculative opportunity.

Risk Factors and Long-Term Performance Context

CHM.CN’s historical performance reveals significant volatility and long-term decline. Over five years, the stock has fallen 80.39%, while the ten-year return shows a 93.33% loss. The all-time maximum drawdown reaches 98.97%, illustrating the extreme risk profile of this security.

Key risks include venture capital concentration risk, illiquidity in portfolio companies, and the company’s ongoing cash burn. The negative working capital of -C$520,504 and tangible asset value of -C$705,780 underscore balance sheet fragility. Investors must recognize that venture capital investments typically require 5-10 year holding periods with high failure rates. CHM.CN is suitable only for risk-tolerant investors with long time horizons and diversified portfolios.

Final Thoughts

CHM.CN stock’s 900% surge to C$0.05 marks a significant inflection point for Waverunner Capital Inc. following its venture capital rebranding. The company’s focused investment strategy targeting early-stage companies across renewable energy, biotechnology, and consumer sectors offers compelling growth potential. However, negative earnings, weak liquidity ratios, and ongoing cash burn demand cautious evaluation. The B-grade from Meyka AI reflects this balanced risk-reward profile. Investors should view CHM.CN as a speculative venture play requiring thorough due diligence and portfolio diversification. The CNQ exchange listing provides Canadian investors direct exposure to emerging venture capital opportunities, but position sizing remains critical given the stock’s penny-stock status and historical volatility. Monitor quarterly updates and portfolio company developments for signs of operational improvement.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.